Clinical Trial Update: A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating evoked potentials as biomarkers of ketamine-induced cortical plasticity in patients with major depressive disorder was terminated; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Major Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2017-01-27